274 related articles for article (PubMed ID: 17971033)
1. Conversion from tacrolimus to cyclosporine A for new-onset diabetes after transplantation: a single-centre experience in renal transplanted patients and review of the literature.
Ghisdal L; Bouchta NB; Broeders N; Crenier L; Hoang AD; Abramowicz D; Wissing KM
Transpl Int; 2008 Feb; 21(2):146-51. PubMed ID: 17971033
[TBL] [Abstract][Full Text] [Related]
2. Conversion from tacrolimus to cyclosporine could improve control of posttransplant diabetes mellitus after renal transplantation.
Ramos-Cebrián M; Torregrosa JV; Gutiérrez-Dalmau A; Oppenheimer F; Campistol JM
Transplant Proc; 2007 Sep; 39(7):2251-3. PubMed ID: 17889154
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up after conversion from tacrolimus to cyclosporin in renal transplant patients with new-onset diabetes mellitus after transplantation.
Batista F; Auyanet I; Torregrosa JV; Oppenheimer F
Transplant Proc; 2012 Nov; 44(9):2582-4. PubMed ID: 23146461
[TBL] [Abstract][Full Text] [Related]
4. Glucose metabolism before and after conversion from cyclosporine microemulsion to tacrolimus in stable renal recipients.
Gelens MA; Christiaans MH; van Hooff JP
Nephrol Dial Transplant; 2008 Feb; 23(2):701-6. PubMed ID: 17999993
[TBL] [Abstract][Full Text] [Related]
5. The combined effect of pre-transplant triglyceride levels and the type of calcineurin inhibitor in predicting the risk of new onset diabetes after renal transplantation.
Porrini E; Delgado P; Alvarez A; Cobo M; Pérez L; González-Posada JM; Hortal L; Gallego R; García JJ; Checa M; Morales A; Salido E; Hernández D; Torres A
Nephrol Dial Transplant; 2008 Apr; 23(4):1436-41. PubMed ID: 18029372
[TBL] [Abstract][Full Text] [Related]
6. Immunosuppressive medications, clinical and metabolic parameters in new-onset diabetes mellitus after kidney transplantation.
Roland M; Gatault P; Doute C; Büchler M; Al-Najjar A; Barbet C; Chatelet V; Marlière JF; Nivet H; Lebranchu Y; Halimi JM
Transpl Int; 2008 Jun; 21(6):523-30. PubMed ID: 18266773
[TBL] [Abstract][Full Text] [Related]
7. Tacrolimus and angiotensin receptor blockers associated with changes in serum adiponectin level in new-onset diabetes after renal transplantation: single-center cross-sectional analysis.
Nishimura K; Kishikawa H; Kato T; Kobayashi Y; Fujii N; Takahara S; Ichikawa Y
Transpl Int; 2009 Jul; 22(7):694-701. PubMed ID: 19254242
[TBL] [Abstract][Full Text] [Related]
8. Optimizing tacrolimus therapy in the maintenance of renal allografts: 12-month results.
Bolin P; Shihab FS; Mulloy L; Henning AK; Gao J; Bartucci M; Holman J; First MR;
Transplantation; 2008 Jul; 86(1):88-95. PubMed ID: 18622283
[TBL] [Abstract][Full Text] [Related]
9. Immediate conversion from tacrolimus to cyclosporine in the treatment of posttransplantation diabetes mellitus.
Oberholzer J; Thielke J; Hatipoglu B; Testa G; Sankary HN; Benedetti E
Transplant Proc; 2005 Mar; 37(2):999-1000. PubMed ID: 15848603
[TBL] [Abstract][Full Text] [Related]
10. One-year observation of kidney allograft recipients converted from cyclosporine microemulsion to tacrolimus.
Chamienia A; Biedunkiewicz B; Król E; Debska-Slizień A; Rutkowski B
Transplant Proc; 2006; 38(1):81-5. PubMed ID: 16504670
[TBL] [Abstract][Full Text] [Related]
11. Predictors of new onset diabetes after renal transplantation.
Joss N; Staatz CE; Thomson AH; Jardine AG
Clin Transplant; 2007; 21(1):136-43. PubMed ID: 17302602
[TBL] [Abstract][Full Text] [Related]
12. Relative risk of new-onset diabetes during the first year after renal transplantation in patients receiving tacrolimus or cyclosporine immunosuppression.
Hoitsma AJ; Hilbrands LB
Clin Transplant; 2006; 20(5):659-64. PubMed ID: 16968494
[TBL] [Abstract][Full Text] [Related]
13. Diabetes mellitus after transplant: relationship to pretransplant glucose metabolism and tacrolimus or cyclosporine A-based therapy.
Sato T; Inagaki A; Uchida K; Ueki T; Goto N; Matsuoka S; Katayama A; Haba T; Tominaga Y; Okajima Y; Ohta K; Suga H; Taguchi S; Kakiya S; Itatsu T; Kobayashi T; Nakao A
Transplantation; 2003 Nov; 76(9):1320-6. PubMed ID: 14627910
[TBL] [Abstract][Full Text] [Related]
14. Tacrolimus as secondary intervention vs. cyclosporine continuation in patients at risk for chronic renal allograft failure.
Waid T;
Clin Transplant; 2005 Oct; 19(5):573-80. PubMed ID: 16146546
[TBL] [Abstract][Full Text] [Related]
15. Paired kidney analysis of tacrolimus and cyclosporine microemulsion-based therapy in Chinese cadaveric renal transplant recipients.
Cheung CY; Wong KM; Chan HW; Liu YL; Chan YH; Wong HS; Chak WL; Choi KS; Chau KF; Li CS
Transpl Int; 2006 Aug; 19(8):657-66. PubMed ID: 16827683
[TBL] [Abstract][Full Text] [Related]
16. Rationale and design of the DIRECT study: a comparative assessment of the hyperglycemic effects of tacrolimus and cyclosporine following renal transplantation.
Vincenti F; Rostaing L;
Contemp Clin Trials; 2005 Feb; 26(1):17-24. PubMed ID: 15837449
[TBL] [Abstract][Full Text] [Related]
17. Hypomagnesemia and the risk of new-onset diabetes after liver transplantation.
Van Laecke S; Desideri F; Geerts A; Van Vlierberghe H; Berrevoet F; Rogiers X; Troisi R; de Hemptinne B; Vanholder R; Colle I
Liver Transpl; 2010 Nov; 16(11):1278-87. PubMed ID: 21031543
[TBL] [Abstract][Full Text] [Related]
18. New-onset diabetes after transplantation: assessment of risk factors and clinical outcomes.
Cotovio P; Neves M; Rodrigues L; Alves R; Bastos M; Baptista C; Macário F; Mota A
Transplant Proc; 2013 Apr; 45(3):1079-83. PubMed ID: 23622631
[TBL] [Abstract][Full Text] [Related]
19. Regression of new-onset diabetes mellitus after conversion from tacrolimus to cyclosporine in liver transplant patients: results of a pilot study.
Lorho R; Hardwigsen J; Dumortier J; Pageaux GP; Durand F; Bizollon T; Blanc AS; Di Giambattista F; Duvoux C
Clin Res Hepatol Gastroenterol; 2011 Jun; 35(6-7):482-8. PubMed ID: 21530445
[TBL] [Abstract][Full Text] [Related]
20. New-onset diabetes after transplantation--should it be a factor in choosing an immunosuppressant regimen for kidney transplant recipients.
Chadban S
Nephrol Dial Transplant; 2008 Jun; 23(6):1816-8. PubMed ID: 18326882
[No Abstract] [Full Text] [Related]
[Next] [New Search]